Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Evolent Health, Inc.EVH · Entity 5492 | Director · Chief Executive Officer | July 01, 2026 | July 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Evolent Health, Inc.
Report date July 01, 2026 · Filed July 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 1,283,064 |
Reported balance
After 2026-07-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-07-01 · Grant · Acquired 446,102 · Balance 1,283,064 F1: Represents restricted stock units granted to Mr. Blackley pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2: Represents a portion of the award approved by the Compensation Committee of the Company's Board of Directors as part of the annual award cycle. The first portion of the award was granted on March 2, 2026, and this portion of the award was granted on July 1, 2026, following the issuance of additional shares under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. The Company's shareholders approved the issuance of additional shares under the Amended and Restated 2015 Omnibus Incentive Compensation Plan on June 4, 2026, at the Company's Annual Meeting. F3: Securities vest at a rate of 34% on July 1, 2027, and 33% on July 1, 2028, and July 1, 2029. F4: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
| Class A Common StockSEC Table I · non-derivative | Direct | 1,272,767 |
Reported balance
After 2026-07-01 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-07-01 · Tax withholding · Disposed 10,297 · Balance 1,272,767 F5: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. F4: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units granted to Mr. Blackley pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
F2: Represents a portion of the award approved by the Compensation Committee of the Company's Board of Directors as part of the annual award cycle. The first portion of the award was granted on March 2, 2026, and this portion of the award was granted on July 1, 2026, following the issuance of additional shares under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. The Company's shareholders approved the issuance of additional shares under the Amended and Restated 2015 Omnibus Incentive Compensation Plan on June 4, 2026, at the Company's Annual Meeting.
F3: Securities vest at a rate of 34% on July 1, 2027, and 33% on July 1, 2028, and July 1, 2029.
F4: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F5: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 21, 2022 Filed Nov 24, 2022 00:50 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionClass A Common Stock | 75,000 | $3.84 | $288,000.00 |
DisclosureSEC source: 0001628908-22-000156 · wf-form4_166925103286679.xml · nonDerivative · entry 1 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 497,037 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2022. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 03, 2022 Filed Mar 5, 2022 02:01 UTC | Evolent Health, Inc. EVH · Entity 5492 | Tax withholdingClass A Common Stock | 129,378 | $27.54 | $3,563,070.12 |
DisclosureSEC source: 0001628908-22-000045 · wf-form4_164644567295512.xml · nonDerivative · entry 2 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 422,037 F3 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of leveraged stock units. F2 · balance_after: Includes restricted stock units granted under awards reported on Table I of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 02, 2022 Filed Mar 5, 2022 02:01 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionLeveraged Restricted Stock Unit · Derivative | 286,867 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628908-22-000045 · wf-form4_164644567295512.xml · derivative · entry 3 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 286,867 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Leveraged Stock Units vested on March 2, 2022. F5 · derivative.expiration_date: These Leveraged Stock Units do not expire. Read SEC document |
| March 02, 2022 Filed Mar 5, 2022 02:01 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionClass A Common Stock | 286,867 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-22-000045 · wf-form4_164644567295512.xml · nonDerivative · entry 1 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 551,415 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting of the leveraged stock units granted to Mr. Blackley on March 1, 2019, based on the cumulative performance of the Issuer's Class A Common Stock. F2 · balance_after: Includes restricted stock units granted under awards reported on Table I of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 02:25 UTC | Evolent Health, Inc. EVH · Entity 5492 | Tax withholdingClass A Common Stock | 5,285 | $27.40 | $144,809.00 |
DisclosureSEC source: 0001628908-22-000035 · wf-form4_164636073453327.xml · nonDerivative · entry 2 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,548 F4 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 02:25 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 64,991 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-22-000035 · wf-form4_164636073453327.xml · nonDerivative · entry 1 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,833 F1 · security: Represents restricted stock units granted to Mr. Blackley pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest at a rate of 34% on March 1, 2023, and 33 % on March 1, 2024, and March 1, 2025. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| October 15, 2021 Filed Oct 20, 2021 01:15 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionClass A Common Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $3.84 | $0.00 |
DisclosureSEC source: 0001628908-21-000135 · wf-form4_163469248900793.xml · derivative · entry 3 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,040 Underlying: Class A Common Stock · 150,000 shares Expires 2024-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2021. F4 · derivative.exercise_date: The Class A Common Stock Options exercised vested on December 1, 2015 and December 1, 2016. Read SEC document |
| October 15, 2021 Filed Oct 20, 2021 01:15 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 150,000 | $29.86 | $4,479,000.00 |
DisclosureSEC source: 0001628908-21-000135 · wf-form4_163469248900793.xml · nonDerivative · entry 2 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,842 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.66 to $30.07, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| October 15, 2021 Filed Oct 20, 2021 01:15 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionClass A Common Stock | 150,000 | $3.84 | $576,000.00 |
DisclosureSEC source: 0001628908-21-000135 · wf-form4_163469248900793.xml · nonDerivative · entry 1 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,842 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2021. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:39 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 46,866 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-21-000028 · wf-form4_161482197473209.xml · nonDerivative · entry 1 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,842 F1 · security: Represents restricted stock units granted to Mr. Blackley pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation plan. F2 · shares: Securities vest at a rate of 25% annually beginning March 1, 2022. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| June 04, 2020 Filed Jun 5, 2020 21:48 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantLeveraged Restricted Stock Unit · Derivative | 140,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628908-20-000070 · wf-form4_159139372184815.xml · derivative · entry 1 Blackley Seth · CIK 0001643346 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Class A Common Stock · 140,000 shares Expires not disclosed F1 · derivative.exercise_date: These securities vest on December 4, 2023. F2 · derivative.expiration_date: These securities do not expire. F3 · derivative.underlying_shares: Each leveraged stock unit ("LSU") represents the contingent right to receive, upon vesting, between 0% and 200% of one share of the Issuer's Class A Common Stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the LSUs, if any, is based on the cumulative performance of the Issuer's Class A Common Stock. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:55 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantLeveraged Restricted Stock Unit · Derivative | 180,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628908-20-000036 · wf-form4_158335889433356.xml · derivative · entry 1 Blackley Seth · CIK 0001643346 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,000 Underlying: Class A Common Stock · 180,000 shares Expires not disclosed F1 · derivative.exercise_date: These LSUs vest on March 2, 2023. F2 · derivative.expiration_date: These LSUs do not expire. F3 · derivative.underlying_shares: Each leveraged stock unit ("LSU") represents the contingent right to receive, upon vesting, between 0% and 200% of one share of the Issuer's Class A common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the LSUs, if any, is based on the cumulative performance of the Issuer's Class A common stock. Read SEC document |
| December 04, 2019 Filed Dec 5, 2019 22:16 UTC | Evolent Health, Inc. EVH · Entity 5492 | PurchaseClass A Common Stock | 14,749 | $6.73 | $99,260.77 |
DisclosureSEC source: 0001628908-19-000076 · wf-form4_157558418569337.xml · nonDerivative · entry 1 Blackley Seth · CIK 0001643346 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,976 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $ 6.70 to $6.78, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 22:23 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantLeveraged Restricted Stock Unit · Derivative | 186,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628908-19-000012 · primary_doc.xml · derivative · entry 1 Blackley Seth · CIK 0001643346 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,750 Underlying: Class A Common Stock · 186,750 shares Expires not disclosed F1 · shares: Each leveraged stock unit ("LSU") represents the contingent right to receive, upon vesting, between 0% and 200% of one share of the Issuer's Class A common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the LSUs, if any, is based on the cumulative performance of the Issuer's Class A common stock. F2 · derivative.exercise_date: These LSUs vest on March 2, 2022. F3 · derivative.expiration_date: These LSUs do not expire. F1 · derivative.underlying_shares: Each leveraged stock unit ("LSU") represents the contingent right to receive, upon vesting, between 0% and 200% of one share of the Issuer's Class A common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the LSUs, if any, is based on the cumulative performance of the Issuer's Class A common stock. Read SEC document |
| July 06, 2018 Filed Jul 10, 2018 21:28 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionClass A Common Option (Right to Buy) · Derivative | 31,554 | $0.00 Strike: $3.84 | $0.00 |
DisclosureSEC source: 0001628908-18-000058 · primary_doc.xml · derivative · entry 4 Blackley Seth · CIK 0001643346 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 336,040 Underlying: Class A Common Stock · 31,554 shares Expires 2024-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. F5 · derivative.exercise_date: The Class A Common Stock Options exercised vested on December 1, 2015. Read SEC document |
| July 06, 2018 Filed Jul 10, 2018 21:28 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 31,554 | $22.74 | $717,537.96 |
DisclosureSEC source: 0001628908-18-000058 · primary_doc.xml · nonDerivative · entry 3 Blackley Seth · CIK 0001643346 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,227 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. F4 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $22.55-$23.00, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| July 06, 2018 Filed Jul 10, 2018 21:28 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionClass A Common Stock | 31,554 | $3.84 | $121,167.36 |
DisclosureSEC source: 0001628908-18-000058 · primary_doc.xml · nonDerivative · entry 2 Blackley Seth · CIK 0001643346 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,781 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. F3 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| July 06, 2018 Filed Jul 10, 2018 21:28 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 20,610 | $22.72 | $468,259.20 |
DisclosureSEC source: 0001628908-18-000058 · primary_doc.xml · nonDerivative · entry 1 Blackley Seth · CIK 0001643346 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,227 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. F2 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $22.55-$23.00, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| July 05, 2018 Filed Jul 6, 2018 20:29 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionClass A Common Option (Right to Buy) · Derivative | 32,643 | $0.00 Strike: $3.84 | $0.00 |
DisclosureSEC source: 0001628908-18-000057 · primary_doc.xml · derivative · entry 8 Blackley Seth · CIK 0001643346 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 367,594 Underlying: Class A Common Stock · 32,643 shares Expires 2024-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. F8 · derivative.exercise_date: The Class A Common Stock Options exercised vested on December 1, 2014 and December 1, 2015. Read SEC document |
| July 05, 2018 Filed Jul 6, 2018 20:29 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 32,643 | $22.51 | $734,793.93 |
DisclosureSEC source: 0001628908-18-000057 · primary_doc.xml · nonDerivative · entry 6 Blackley Seth · CIK 0001643346 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,837 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. F7 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $22.250-$22.775, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| July 05, 2018 Filed Jul 6, 2018 20:29 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionClass A Common Stock | 32,643 | $3.84 | $125,349.12 |
DisclosureSEC source: 0001628908-18-000057 · primary_doc.xml · nonDerivative · entry 5 Blackley Seth · CIK 0001643346 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,480 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. F3 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| July 05, 2018 Filed Jul 6, 2018 20:29 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 33,467 | $22.52 | $753,676.84 |
DisclosureSEC source: 0001628908-18-000057 · primary_doc.xml · nonDerivative · entry 4 Blackley Seth · CIK 0001643346 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,837 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. F6 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $22.250-$22.775, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| July 03, 2018 Filed Jul 6, 2018 20:29 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionClass A Common Option (Right to Buy) · Derivative | 48,930 | $0.00 Strike: $3.84 | $0.00 |
DisclosureSEC source: 0001628908-18-000057 · primary_doc.xml · derivative · entry 7 Blackley Seth · CIK 0001643346 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,237 Underlying: Class A Common Stock · 48,930 shares Expires 2024-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. F5 · derivative.exercise_date: The Class A Common Stock Options exercised vested on December 1, 2014. Read SEC document |
| July 03, 2018 Filed Jul 6, 2018 20:29 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 48,930 | $22.16 | $1,084,288.80 |
DisclosureSEC source: 0001628908-18-000057 · primary_doc.xml · nonDerivative · entry 3 Blackley Seth · CIK 0001643346 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,304 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. F4 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $21.60-$22.60, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| July 03, 2018 Filed Jul 6, 2018 20:29 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionClass A Common Stock | 48,930 | $3.84 | $187,891.20 |
DisclosureSEC source: 0001628908-18-000057 · primary_doc.xml · nonDerivative · entry 2 Blackley Seth · CIK 0001643346 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. F3 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| July 03, 2018 Filed Jul 6, 2018 20:29 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 49,099 | $22.16 | $1,088,033.84 |
DisclosureSEC source: 0001628908-18-000057 · primary_doc.xml · nonDerivative · entry 1 Blackley Seth · CIK 0001643346 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,304 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. F2 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $21.60-$22.60, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 21:07 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionClass A Common Option (right to buy) · Derivative | 41,873 | $0.00 Strike: $3.84 | $0.00 |
DisclosureSEC source: 0001628908-18-000056 · primary_doc.xml · derivative · entry 4 Blackley Seth · CIK 0001643346 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 449,167 Underlying: Class A Common Stock · 41,873 shares Expires 2024-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. F5 · derivative.exercise_date: The Class A Common Stock Options exercised vested on December 1, 2014. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 21:07 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 41,873 | $21.22 | $888,545.06 |
DisclosureSEC source: 0001628908-18-000056 · primary_doc.xml · nonDerivative · entry 3 Blackley Seth · CIK 0001643346 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,403 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. F4 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $20.65-$21.60, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 21:07 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionClass A Common Stock | 41,873 | $3.84 | $160,792.32 |
DisclosureSEC source: 0001628908-18-000056 · primary_doc.xml · nonDerivative · entry 2 Blackley Seth · CIK 0001643346 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. F3 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 21:07 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 41,824 | $21.21 | $887,087.04 |
DisclosureSEC source: 0001628908-18-000056 · primary_doc.xml · nonDerivative · entry 1 Blackley Seth · CIK 0001643346 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,403 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. F2 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $20.65-$21.60, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| June 18, 2018 Filed Jun 20, 2018 20:31 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 16,674 | $23.33 | $389,004.42 |
DisclosureSEC source: 0001628908-18-000052 · primary_doc.xml · nonDerivative · entry 1 Blackley Seth · CIK 0001643346 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,227 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2017. F2 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $23.20-$23.50, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 21:32 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 2,885 | $20.95 | $60,440.75 |
DisclosureSEC source: 0001628908-18-000038 · primary_doc.xml · nonDerivative · entry 2 Blackley Seth · CIK 0001643346 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,901 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2017. F4 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $20.90-$21.00, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate prices within the range set forth in this footnote. F3 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 21:32 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 13,781 | $20.34 | $280,305.54 |
DisclosureSEC source: 0001628908-18-000038 · primary_doc.xml · nonDerivative · entry 1 Blackley Seth · CIK 0001643346 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,786 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2017. F2 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $19.85-$20.85, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| May 21, 2018 Filed May 23, 2018 20:40 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 16,666 | $19.39 | $323,153.74 |
DisclosureSEC source: 0001628908-18-000034 · primary_doc.xml · nonDerivative · entry 1 Blackley Seth · CIK 0001643346 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,567 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2017. F2 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $19.25-$19.55, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| May 10, 2018 Filed May 11, 2018 20:48 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 64,398 | $17.63 | $1,135,336.74 |
DisclosureSEC source: 0001628908-18-000031 · primary_doc.xml · nonDerivative · entry 1 Blackley Seth · CIK 0001643346 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,233 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2017. F2 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $17.15-$18.35, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| May 08, 2018 Filed May 9, 2018 20:24 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 5,124 | $17.00 | $87,108.00 |
DisclosureSEC source: 0001628908-18-000026 · primary_doc.xml · nonDerivative · entry 2 Blackley Seth · CIK 0001643346 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 402,631 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2017. F3 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| May 07, 2018 Filed May 9, 2018 20:24 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 80,472 | $17.09 | $1,375,266.48 |
DisclosureSEC source: 0001628908-18-000026 · primary_doc.xml · nonDerivative · entry 1 Blackley Seth · CIK 0001643346 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 407,755 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2017. F2 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $17.00-$17.30, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of share sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 21:59 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock Option (right to buy) · Derivative | 101,010 | $0.00 Strike: $13.95 | $0.00 |
DisclosureSEC source: 0001628908-18-000004 · primary_doc.xml · derivative · entry 2 Blackley Seth · CIK 0001643346 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,010 Underlying: Class A Common Stock · 101,010 shares Expires 2028-02-01 F4 · derivative.exercise_date: Securities vest at a rate of 25% annually beginning February 1, 2019. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 21:59 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 86,022 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-18-000004 · primary_doc.xml · nonDerivative · entry 1 Blackley Seth · CIK 0001643346 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 488,227 F1 · security: Represents restricted stock units granted to Mr. Blackley pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest at a rate of 25% annually beginning February 1, 2019. F3 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| June 15, 2017 Filed Jun 19, 2017 20:15 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 15,000 | $25.22 | $378,300.00 |
DisclosureSEC source: 0001628908-17-000033 · primary_doc.xml · nonDerivative · entry 1 Blackley Seth · CIK 0001643346 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 402,205 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2016. F2 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $25.00-$25.55, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 20:38 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 15,000 | $22.86 | $342,900.00 |
DisclosureSEC source: 0001643346-17-000010 · primary_doc.xml · nonDerivative · entry 1 Blackley Seth · CIK 0001643346 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 417,205 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2016. F2 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $22.60-$23.55, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes restricted stock units under awards reported on Table 1 of the Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| May 19, 2017 Filed May 23, 2017 22:25 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 114,865 | $24.30 | $2,791,219.50 |
DisclosureSEC source: 0000950157-17-000721 · form4.xml · nonDerivative · entry 1 Blackley Seth · CIK 0001643346 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 432,205 F1 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| May 15, 2017 Filed May 17, 2017 22:05 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 15,000 | $25.00 | $375,000.00 |
DisclosureSEC source: 0001643346-17-000009 · primary_doc.xml · nonDerivative · entry 1 Blackley Seth · CIK 0001643346 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 760,944 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2016. F2 · price: The price reported in Column4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $24.90-$25.35, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 01, 2017 Filed May 3, 2017 20:45 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 15,000 | $23.11 | $346,650.00 |
DisclosureSEC source: 0001643346-17-000008 · primary_doc.xml · nonDerivative · entry 1 Blackley Seth · CIK 0001643346 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 775,944 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reported person on September 9, 2016. F2 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $22.875-$23.35, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 17, 2017 Filed Apr 19, 2017 21:37 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 3,658 | $21.88 | $80,037.04 |
DisclosureSEC source: 0001643346-17-000007 · primary_doc.xml · nonDerivative · entry 2 Blackley Seth · CIK 0001643346 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 790,944 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2016. F3 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $21.825-$21.925, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 17, 2017 Filed Apr 19, 2017 21:37 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 11,342 | $21.35 | $242,151.70 |
DisclosureSEC source: 0001643346-17-000007 · primary_doc.xml · nonDerivative · entry 1 Blackley Seth · CIK 0001643346 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 794,602 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2016. F2 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $20.80-$21.80, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 30, 2017 Filed Mar 31, 2017 20:52 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 1,284 | $21.76 | $27,939.84 |
DisclosureSEC source: 0001643346-17-000006 · primary_doc.xml · nonDerivative · entry 2 Blackley Seth · CIK 0001643346 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 805,944 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2016. F3 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $21.725-$21.85, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 30, 2017 Filed Mar 31, 2017 20:52 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 13,716 | $21.14 | $289,956.24 |
DisclosureSEC source: 0001643346-17-000006 · primary_doc.xml · nonDerivative · entry 1 Blackley Seth · CIK 0001643346 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 807,228 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2016. F2 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $20.70-$21.65, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 20:43 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 4,604 | $21.29 | $98,019.16 |
DisclosureSEC source: 0001643346-17-000005 · primary_doc.xml · nonDerivative · entry 2 Blackley Seth · CIK 0001643346 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 820,944 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2016. F3 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $21.20-$21.40, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 20:43 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 10,396 | $20.68 | $214,989.28 |
DisclosureSEC source: 0001643346-17-000005 · primary_doc.xml · nonDerivative · entry 1 Blackley Seth · CIK 0001643346 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 825,548 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2016. F2 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $20.15-$21.10, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate prices within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.